Compare PRCT & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRCT | AHG |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2021 | 2017 |
| Metric | PRCT | AHG |
|---|---|---|
| Price | $20.55 | $1.32 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $35.44 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 6.7K |
| Earning Date | 04-29-2026 | 08-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $308,054,000.00 | N/A |
| Revenue This Year | $31.34 | N/A |
| Revenue Next Year | $24.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 37.22 | N/A |
| 52 Week Low | $16.67 | $1.10 |
| 52 Week High | $42.71 | $2.50 |
| Indicator | PRCT | AHG |
|---|---|---|
| Relative Strength Index (RSI) | 52.75 | 38.85 |
| Support Level | $19.64 | $1.24 |
| Resistance Level | $29.27 | $1.64 |
| Average True Range (ATR) | 1.15 | 0.11 |
| MACD | 0.39 | -0.02 |
| Stochastic Oscillator | 99.12 | 6.64 |
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.